Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
暂无分享,去创建一个
Max A. Horlbeck | Luke A. Gilbert | Martin Kampmann | Chaitan Khosla | Max A Horlbeck | Luke A Gilbert | C. Khosla | J. Carette | J. Glenn | D. Morgens | Amy Li | M. Bassik | M. Kampmann | Richard M. Deans | Sirika Pillay | Roberto Mateo | Ayşe Ökesli | Mark Smith | Jeffrey S Glenn | Amy Li | David W Morgens | Michael C Bassik | Jan E Carette | Sirika Pillay | Roberto Mateo | Mark Smith | Richard M Deans | Ayşe Ökesli
[1] Pamela L. Golden,et al. Tetrahydrocarbazole amides with potent activity against human papillomaviruses. , 2009, Bioorganic & medicinal chemistry letters.
[2] D. E. Patterson,et al. Efficient Asymmetric Synthesis of N-[(1R)-6-Chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl]-2-pyridinecarboxamide for Treatment of Human Papillomavirus Infections , 2007 .
[3] P. Clemons,et al. Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.
[4] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[5] Avi Ma'ayan,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[6] P. Shi,et al. Characterization of Dengue Virus Resistance to Brequinar in Cell Culture , 2010, Antimicrobial Agents and Chemotherapy.
[7] J. Roehrig,et al. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. , 1997, Virology.
[8] Wei Zhang,et al. Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System , 2014, Cell.
[9] L. Kramer,et al. Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis , 2011, Journal of Virology.
[10] S. Bavari,et al. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. , 2012, Antiviral research.
[11] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[12] J. Neyts,et al. Intervention strategies for emerging viruses: use of antivirals , 2013, Current Opinion in Virology.
[13] Michael T. McManus,et al. Rapid Creation and Quantitative Monitoring of High Coverage shRNA Libraries , 2009, Nature Methods.
[14] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[15] E. Lander,et al. Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.
[16] Michael I. Jordan,et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Sabatini,et al. Regulation of mTORC1 by amino acids. , 2014, Trends in cell biology.
[18] M. Kinch,et al. Development of a broad-spectrum antiviral with activity against Ebola virus. , 2009, Antiviral research.
[19] A. Gamarnik,et al. Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation , 2009, PLoS pathogens.
[20] Max A. Horlbeck,et al. Next-generation libraries for robust RNA interference-based genome-wide screens , 2015, Proceedings of the National Academy of Sciences.
[21] John A. Tallarico,et al. Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) , 2011, Proceedings of the National Academy of Sciences.
[22] N. Krogan,et al. Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response , 2015, eLife.
[23] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[24] Jennifer Doudna,et al. RNA-programmed genome editing in human cells , 2013, eLife.
[25] Matthew Meyerson,et al. A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1 , 2013, Science.
[26] Michael T. McManus,et al. Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens. , 2013, Chemistry & biology.
[27] Michael T. McManus,et al. A Systematic Mammalian Genetic Interaction Map Reveals Pathways Underlying Ricin Susceptibility , 2013, Cell.
[28] G. Wahl,et al. Mechanism of action for leflunomide in rheumatoid arthritis. , 1999, Clinical immunology.
[29] W. Knecht,et al. Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase. , 1998, Protein expression and purification.
[30] J. Clardy,et al. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. , 2000, Structure.
[31] U. Sauer,et al. Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis , 2013, Science.
[32] Peter S. Kutchukian,et al. Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.
[33] J. Irwin,et al. Identifying mechanism-of-action targets for drugs and probes , 2012, Proceedings of the National Academy of Sciences.
[34] Jack Parker Davis,et al. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. , 1996, Biochemistry.
[35] H. Simmonds,et al. T-lymphocytes from AIDS Patients Are Unable to Synthesize Ribonucleotides de Novo in Response to Mitogenic Stimulation , 1995, The Journal of Biological Chemistry.
[36] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[37] N. Perrimon,et al. High-throughput RNAi screening in cultured cells: a user's guide , 2006, Nature Reviews Genetics.
[38] J. Asara,et al. Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1 , 2013, Science.
[39] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[40] Inmar E. Givoni,et al. Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast , 2006, Cell.
[41] Max A. Horlbeck,et al. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.
[42] V. Simon,et al. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis , 2011, Proceedings of the National Academy of Sciences.
[43] J. Weissman,et al. Functional genomics platform for pooled screening and generation of mammalian genetic interaction maps , 2014, Nature Protocols.
[44] J. Strum,et al. GSK983: A novel compound with broad-spectrum antiviral activity , 2009, Antiviral Research.
[45] E. Frolova,et al. Interplay of Acute and Persistent Infections Caused by Venezuelan Equine Encephalitis Virus Encoding Mutated Capsid Protein , 2010, Journal of Virology.
[46] W. Knecht,et al. Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase. A versatile tool to rate inhibitor effects? , 2001, European journal of biochemistry.
[47] H. Simmonds,et al. Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans , 1995, The Journal of Biological Chemistry.
[48] Yuna Sun,et al. Current progress in antiviral strategies , 2014, Trends in Pharmacological Sciences.
[49] M. Kinch,et al. FGI-104: a broad-spectrum small molecule inhibitor of viral infection. , 2009, American journal of translational research.
[50] Martin Kampmann,et al. Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells , 2013, Proceedings of the National Academy of Sciences.